BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 12, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 17, 2009

View Archived Issues

Yonsei University scientists disclose novel oncolytic compounds

Read More

Entecavir exhibits superior antiviral activity to adefovir in CHB patients

Read More

Vicriviroc exhibits long-term safety in phase II HIV trials, phase III trials under way

Read More

PEG-Interferon lambda effective in HCV genotype 1 relapsed patients

Read More

Taribavirin has anemia benefits versus ribavirin in HCV patients

Read More

IMO-2125 shows promising anti-HCV activity in preclinical evaluation

Read More

New vanilloid TRPV1 receptor ligands claimed by sanofi-aventis as analgesics

Read More

Protein kinase inhibitors in development at IRM for the treatment of cancer

Read More

Novel antiparkinsonian compounds described by Israeli scientists

Read More

Spherix reports interim results of phase III trial of D-tagatose in diabetes

Read More

FDA approves Lysteda for the treatment of menorrhagia

Read More

Alkermes reports results from phase III naltrexone trial for opioid dependence

Read More

Aegerion reports additional lomitapide phase III data

Read More

Winston Laboratories reports topline results of phase II civamide patch trial

Read More

Esperion Therapeutics initiates phase I ETC-1002 trial in healthy volunteers

Read More

Genzyme receives FDA complete response letter on Lumizyme marketing application

Read More

Eisai launches Lusedra injection for monitored anesthesia care sedation

Read More

Seattle Genetics initiates phase I SGN-75 trial in patients with cancer

Read More

Poniard's phase III trial of picoplatin in lung cancer does not meet primary endpoint

Read More

Brookstone Pharmaceuticals becomes Acella Pharmaceuticals

Read More

Onyx acquires Proteolix

Read More

Sciele Pharma to acquire Addrenex

Read More

SB-939 shows favorable PK, PD and safety in phase I trial in advanced solid tumors

Read More

COMP recommends orphan drug status for Proteo's Elafin in esophagus carcinoma

Read More

GSK and Nabi sign option and licensing agreement for NicVAX nicotine vaccine

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 11, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 11, 2025.
  • AI-generated illustration of heart and metabolic impact

    Deep Apple signs big Novo deal for cardiometabolic small molecules

    BioWorld
    Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
  • DNA double helix under a magnifying glass

    23andme genetic privacy concerns garner Congressional scrutiny

    BioWorld MedTech
    The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...
  • Red and blue bispecific antibodies

    3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race

    BioWorld
    3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing